Quirong, Qiana .

HRN: 21-72-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/28/2025
01/03/2026
IV
500mg
Q6
URTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines